Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature

K.J. Gotink, H.J. Broxterman, R.J. Honeywell, H. Dekker, R.R. de Haas, K.M. Miles, R. Adelaiye, A.W. Griffioen, G.J. Peters, R. Pili, H.M.W. Verheul

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)844-853
JournalOncoscience
Volume1
Issue number12
Publication statusPublished - 2014

Cite this